Patents by Inventor Paul E. Wiedeman

Paul E. Wiedeman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anaphylatoxin-receptor ligands
    Patent number: 5223485
    Abstract: Oligopeptide compounds or oligopeptide analogue compounds of the formula A-B-D-E-G-J-L-M-Q-T are ligands for the anaphylatoxin receptor and are useful in the treatment of inflammatory disease states. Also disclosed are anaphylatoxin receptor ligand compositions and a method for modulating anaphylatoxin activity.
    Type: Grant
    Filed: June 19, 1991
    Date of Patent: June 29, 1993
    Assignee: Abbott Laboratories
    Inventors: Megumi Kawai, Yat S. Or, Paul E. Wiedeman, Jay R. Luly, Mikel P. Moyer
  • Terminally modified tri-, tetra- and pentapeptide anaphylatoxin receptor ligands
    Patent number: 5190922
    Abstract: Oligopeptide compounds or oligopeptide analogue compounds of the formula A-B-D-E-G-J-L are ligands for the anaphylatoxin receptor and are useful in the treatment of inflammatory disease states. Also disclosed are anaphylatoxin receptor ligand compositions and a method for modulating anaphylatoxin activity.
    Type: Grant
    Filed: June 4, 1991
    Date of Patent: March 2, 1993
    Assignee: Abbott Laboratories
    Inventors: Jay R. Luly, Megumi Kawai, Paul E. Wiedeman